Search
 

Clark Y. Lin Attorney

Boston, US
c...@...sgr.com (Login to view more)
Practice Areas: Patent Litigation, Patent Prosecution...
(617) ???-???? (Login to view more)
Claim This Profile

PatentsSubscription-Only

57
Patents (All Time)
40
Patents (Past 5 Years)
N/A
Applications (Past 5 Years)
Patents Counts by Examiners
Patents Distribution by IPC
Patents Counts by Companies
Office Actions/Extensions by Year
Issued/Abandoned by Year
Percentage of Foreign Originated Patents by Year

Patents Prosecuted

Application numberTitle of the patentIPCFiling DateDecision Date
17150587 Enalapril formulations A61K Jan 14, 2021 Jun 21, 2021
17133415 Suspensions and diluents for metronidazole and baclofen A61K, A61P Dec 22, 2020 May 9, 2022
16991575 Enalapril formulations A61K Aug 11, 2020 Feb 15, 2021
16883553 Enalapril formulations A61K May 25, 2020 Oct 12, 2020
16853380 Amlodipine formulations A01N, A61K Apr 19, 2020 Jan 18, 2021
16564904 LISINOPRIL FORMULATIONS A61K Sep 8, 2019 May 25, 2021
16381575 Amlodipine formulations A61K Apr 10, 2019 Oct 12, 2020
16295482 Lisinopril formulations A61K Mar 6, 2019 Sep 9, 2019
16242898 Enalapril formulations A61K Jan 7, 2019 Sep 14, 2020
62780890 METHODS OF SUBSTITUTING PATHOGENIC AMINO ACIDS USING PROGRAMMABLE BASE EDITOR SYSTEMS Dec 16, 2018
16177159 Enalapril formulations A61K Oct 30, 2018 Sep 28, 2020
16174157 BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT A61K, C12N, C07K Oct 28, 2018 Apr 9, 2021
16174177 BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT A61K, C07K Oct 28, 2018 Apr 13, 2021
16161986 Single domain serum albumin binding protein C07K, A61K Oct 15, 2018 Sep 26, 2022
62745247 CD33xCD3 BINDING PROTEINS FOR TREATING INFLAMMATORY CONDITIONS AND DISEASES Oct 11, 2018
16159545 B cell maturation antigen binding proteins A61P, A61K, C07K Oct 11, 2018 Feb 22, 2021
62734952 CONDITIONALLY ACTIVE RECEPTORS Sep 20, 2018
62733443 CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE Sep 18, 2018
62733444 CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE Sep 18, 2018
62733435 CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE Sep 18, 2018
Menu